What is the next earnings date for ADXN stock?
ADDEX THERAPEUTICS LTD (ADXN) will report earnings on 2026-05-18.
ADDEX THERAPEUTICS LTD (ADXN) Forecast, Price Target & Analyst Ratings
NASDAQ:ADXN • US00654J2069
Current stock price
6.7 USD
+0.4 (+6.35%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ADDEX THERAPEUTICS LTD (ADXN).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of $6.70 to mean target of N/A, Based on 9 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
40.00%
ADXN was analyzed by 9 analysts. The buy percentage consensus is at 40. So analysts seem to be rather negative about ADXN.
In the previous month the buy percentage consensus was at a similar level.
ADXN was analyzed by 9 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2024-10-02 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-31 | HC Wainwright & Co. | Upgrade | Neutral -> Buy |
| 2022-06-23 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2022-05-31 | HC Wainwright & Co. | Maintains | Buy |
| 2022-02-11 | HC Wainwright & Co. | Maintains | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 18, 2026
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates 2025 - 2031
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.445M -54.17% | 1.617M 11.92% | 410K -74.65% | 765K 86.59% | 765K | -100.00% | |||||
| EBITDA YoY % growth | -20.197M -33.24% | -1.937M 90.41% | -2.495M -28.81% | -3.223M -29.18% | -3.284M -1.90% | -3.162M 3.73% | -2.546M 19.47% | -2.546M | -2.546M | -2.546M | |
| EBIT YoY % growth | -20.52M -32.34% | -2.243M 89.07% | -2.755M -22.84% | -3.305M -19.95% | -3.325M -0.62% | -3.162M 4.91% | -2.546M 19.47% | -2.546M | -2.546M | -2.546M | |
| Operating Margin | -1,420.08% | -138.70% | -672.00% | -432.00% | -434.67% | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | -9.54 76.82% | N/A -33.05% | N/A 103.68% | -6.53 -1,500.00% | -3.73 42.86% | 0.00 100.00% | -0.18 | -0.09 49.87% | 0.04 150.00% | N/A |
All data in CHF
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in CHF
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
-25.99%
EPS Next 5 Year
-17.00%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
-25.99%
Revenue Next 5 Year
-14.87%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
5.45%
EBIT Next 5 Year
5.93%
ADDEX THERAPEUTICS LTD / ADXN Forecast FAQ
Can you provide the expected long term growth rate for ADDEX THERAPEUTICS LTD stock?
The expected long term growth rate for ADDEX THERAPEUTICS LTD (ADXN) is -25.99%.